re: ***looking sick**** RCD shareholders approved the placement of 30M shares at $5.25 per share and the issue of 3.3M options at an exercise price of $5.775 to the Allco Group. The transaction will see Allco increase its interest in RCD to around 25% on a fully diluted basis. More than 90% of proxies were in favour of the transaction. Stockbroker view this as a positive for RCD as it provides the company with the ability to maintain its strong growth rates over the medium-term.
- Forums
- ASX - By Stock
- RCD
- ***looking superb also****
RCD
record investments limited
***looking superb also****, page-6
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online